ASTM F1538-03
(Specification)Standard Specification for Glass and Glass Ceramic Biomaterials for Implantation
Standard Specification for Glass and Glass Ceramic Biomaterials for Implantation
SCOPE
1.1 This specification covers the material requirements and characterization techniques for glass and glass-ceramic biomaterials intended for use as bulk porous or powdered surgical implants, or as coatings on surgical devices, but not including drug delivery systems.
1.2 The biological response to glass and glass-ceramic biomaterials in bone and soft tissue has been demonstrated in clinical use (1-12)2 and laboratory studies (13-17).
1.3 This specification excludes synthetic hydroxylapatite, hydroxylapatite coatings, aluminum oxide ceramics, alpha- and beta-tricalcium phosphate, and whitlockite.
General Information
Relations
Standards Content (Sample)
NOTICE: This standard has either been superseded and replaced by a new version or withdrawn.
Contact ASTM International (www.astm.org) for the latest information
Designation: F 1538 – 03
Standard Specification for
1
Glass and Glass Ceramic Biomaterials for Implantation
This standard is issued under the fixed designation F 1538; the number immediately following the designation indicates the year of
original adoption or, in the case of revision, the year of last revision. A number in parentheses indicates the year of last reapproval. A
superscript epsilon (e) indicates an editorial change since the last revision or reapproval.
1. Scope C 1069 Test Method for Specific Surface Area of Alumina
3
or Quartz by Nitrogen Adsorption
1.1 This specification covers the material requirements and
C 1070 Test Method for Determining Particle Size Distri-
characterization techniques for glass and glass-ceramic bioma-
3
bution of Alumina or Quartz by Laser Light Scattering
terials intended for use as bulk porous or powdered surgical
E 228 Test Method for Linear Thermal Expansion of Solid
implants, or as coatings on surgical devices, but not including
5
Materials with a Vitreous Silica Dilatometer
drug delivery systems.
F 748 Practice for Selecting Generic Biological Test Meth-
1.2 The biological response to glass and glass-ceramic
6
ods for Materials and Devices
biomaterials in bone and soft tissue has been demonstrated in
2
F 981 Practice for Assessment of Compatibility of Bioma-
clinical use (1-12) and laboratory studies (13-17).
terials for Surgical Implants with Respect to Effect of
1.3 This specification excludes synthetic hydroxylapatite,
6
Materials on Muscle and Bone
hydroxylapatitecoatings,aluminumoxideceramics,alpha-and
7
2.2 Code of Federal Regulations:
beta-tricalcium phosphate, and whitlockite.
Title 21, Part 820
8
2. Referenced Documents 2.3 United States Pharmacopoeia:
Lead <252>
2.1 ASTM Standards:
Mercury <261>
C 158 Test Methods for Strength of Glass by Flexure
3
Arsenic <211>
(Determination of Modulus of Rupture)
Heavy Metals <231> Method I
C 169 Test Method for Chemical Analysis of Soda-Lime
9
3
2.4 U.S. Geological Survey Method:
and Borosilicate Glass
Cadmium
C 373 Test Method for Water Absorption, Bulk Density,
Apparent Porosity, andApparent Specific Gravity of Fired
3. Terminology
3
Whiteware Products
3.1 Definitions of Terms Specific to This Standard:
C 623 Test Method for Young’s Modulus, Shear Modulus,
3.1.1 bioactive glass—an amorphous silicate-based solid
and Poisson’s Ratio for Glass and Glass-Ceramics by
3
that is not intrinsically adhesive and that is capable of forming
Resonance
acohesivebondwithbothhardandsofttissuewhenimplanted,
C 633 Test Method for Adhesion or Cohesive Strength of
4
and will develop a hydroxycarbonate apatite layer when
Thermal Sprayed Coatings
3 exposed to appropriate in vitro environments, such as simu-
C 693 Test Method for Density of Glass by Buoyancy
lated body fluid or tris-hydroxymethylaminomethane buffer.
C 729 Test Method for Density of Glass by the Sink-Float
3 3.1.2 bioactive glass-ceramic—an amorphous-derived crys-
Comparator
talline silicate-based solid that is not intrinsically adhesive and
C 730 Test Method for Knoop Indentation Hardness of
3 that is capable of forming a cohesive bond with bone and soft
Glass
tissue when implanted, and will develop a hydroxycarbonate
C 958 Test Method for Particle Size Distribution of Alu-
mina or Quartz by X-Ray Monitoring of Gravity Sedimen-
3
tation
5
Annual Book of ASTM Standards, Vol 14.02.
1 6
This specification is under the jurisdiction of ASTM Committee F04 on Annual Book of ASTM Standards, Vol 13.01.
7
Medical and Surgical Materials and Devices and is the direct responsibility of Available from U.S. Government Printing Office, Superintendent of Docu-
Subcommittee F04.13 on Ceramic Materials. ments, 732 N. Capitol St., NW, Mail Stop: SDE, Washington, DC 20401.
8
Current edition approved Apr. 10, 2003. Published May 2003. Originally Available from United Stated Pharmacopia, 12601 Twinbrook Parkway, Rock-
approved in 1994. Last previous edition approved in 1994 as F 1538 – 94. ville, MD 20852.
2 9
The boldface numbers in parentheses refer to the list of references at the end of Crock, J.G., Felichte, F.E., Briggs, P.H., “Determination of Elements in
this specification. National Bureau of Standards Geological Reference Materials SRM 278 Obsidian
3
Annual Book of ASTM Standards, Vol 15.02. and SRM 688 Basalt by Inductively Coupled Plasma-Atomic Emission Spectrom-
4
Annual Book of ASTM Standards, Vol 02.05. etry,” Geostandards Newsletter, Vol 7, 1983, pp. 335-340.
Copyright © ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959, United States.
1
---------------------- Page: 1 ----------------------
F1538–03
apatite layer when exposed to appropriate in vitro environ- Attempts have been made to relate Knoop hardness to tensile
ments, such as simulated body fluid or tris- strength,butnogenerallyac
...
Questions, Comments and Discussion
Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.